You just read:

Sysmex Inostics' OncoBEAM™ Platform Demonstrates Superior Detection of Clinically-relevant Mutations for Therapy Selection and Molecular Monitoring for Lung and Colon Cancers

News provided by

Sysmex Inostics GmbH

18 Oct, 2018, 11:00 BST